In 2023, respiratory system medicine sales in the UK stood at a specific volume, forming the basis for forecasted growth over the coming years. The forecasted figures from 2024 to 2028 show a consistent year-on-year increase: 0.50% from 2024 to 2025, 0.47% from 2025 to 2026, 0.45% from 2026 to 2027, and 0.47% from 2027 to 2028. The compound annual growth rate (CAGR) over this period is anticipated to be around 0.47%.
Future trends to watch for include advancements in respiratory medicines, changes in healthcare policies, and broader adoption of preventive care measures. The impact of emerging technologies and potential shifts in market demand due to demographic changes could also significantly influence this sector.
